E
Ultragenyx Pharmaceutical Inc. RARE
$29.78 $0.260.88% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Total Cash And Short-Term Investments 487.59M 494.44M 610.03M 607.51M 763.82M
Total Receivables 127.36M 102.84M 123.60M 95.10M 108.28M
Inventory 46.50M 46.03M 45.01M 43.33M 40.14M
Prepaid Expenses 49.31M 47.37M 31.68M -- --
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets 9.04M 8.48M 6.81M 53.67M 52.40M
Total Current Assets 719.79M 699.16M 817.12M 799.61M 964.64M

Total Current Assets 719.79M 699.16M 817.12M 799.61M 964.64M
Net Property, Plant & Equipment 255.76M 260.91M 291.43M 272.45M 278.71M
Long-term Investments 44.41M 44.41M 44.41M 44.41M 44.41M
Goodwill 44.41M 44.41M 44.41M 44.41M 44.41M
Total Other Intangibles 174.73M 176.52M 178.31M 164.94M 166.24M
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets 60.12M 62.37M 37.18M 53.87M 53.77M
Total Assets 1.31B 1.31B 1.50B 1.54B 1.62B

Total Accounts Payable 34.24M 47.45M 38.76M 35.99M 59.81M
Total Accrued Expenses 180.79M 173.01M 240.97M 185.03M 154.42M
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current 75.63M 67.86M 60.14M 59.16M 58.64M
Total Finance Division Other Current Liabilities 2.58M 3.35M 4.28M 4.84M --
Total Other Current Liabilities 2.58M 3.35M 4.28M 4.84M --
Total Current Liabilities 293.24M 291.67M 344.15M 285.01M 272.87M

Total Current Liabilities 293.24M 291.67M 344.15M 285.01M 272.87M
Long-Term Debt 782.75M 794.05M 819.82M 829.69M 842.16M
Short-term Debt -- -- -- -- --
Capital Leases 24.53M 27.79M 30.04M 23.66M 25.74M
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities 47.46M 47.18M 47.14M 46.19M 45.26M
Total Liabilities 1.15B 1.16B 1.24B 1.18B 1.19B

Common Stock & APIC 4.37B 4.25B 4.21B 4.17B 4.12B
Retained Earnings -4.22B -4.11B -3.96B -3.82B -3.69B
Treasury Stock & Other -268.00K -341.00K -643.00K 896.00K -1.10M
Total Common Equity 151.29M 144.25M 255.30M 346.83M 432.42M

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 151.29M 144.25M 255.30M 346.83M 432.42M
Total Preferred Equity -- -- -- -- --
Total Minority Interest 7.00M 7.00M 7.00M 7.00M --
Total Equity 158.29M 151.25M 262.30M 353.83M 432.42M